Improving the Diagnosis of Meningitis in Emergency Rooms

Status Completed

Clinical Trial Summary

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of meningitis caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC diarrhoea tests . This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribonucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribonucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of meningitis after POC test.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Meningitis

Clinical Trial Details

NCT number	NCT02858661
Study type	Interventional
Source	Assistance Publique Hopitaux De Marseille
Contact
Status	Completed
Phase	N/A
Start date	March 30, 2013
Completion date	October 27, 2022

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03445416` - Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men	N/A
Completed	`NCT02526394` - Pertussis and Meningitis C Concomitant Vaccination in Adolescents	Phase 4
Completed	`NCT01442675` - Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine	Phase 2
Completed	`NCT00539032` - Immunology and Safety of Menactra® in Children in Saudi Arabia	Phase 3
Terminated	`NCT00428051` - Colombia Epidemiologic Surveillance Study	N/A
Recruiting	`NCT05496673` - Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda	N/A
Completed	`NCT02003495` - Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine	Phase 3
Recruiting	`NCT00901602` - Lebanese Interhospital Pneumococcal Surveillance Program
Completed	`NCT00850603` - Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®	Phase 4
Completed	`NCT02591290` - Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects	Phase 4
Completed	`NCT03112031` - Treatment With Tamoxifen in Cryptococcal Meningitis	Phase 2
Completed	`NCT02881957` - Hypovitaminosis D in Neurocritical Patients	Phase 2/Phase 3
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Completed	`NCT03378258` - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Recruiting	`NCT05637645` - Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section	N/A
Completed	`NCT02841254` - Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies	N/A
Completed	`NCT02003313` - Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine	Phase 3
Recruiting	`NCT01619462` - Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children	Phase 3
Completed	`NCT01239043` - Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination	Phase 2
Completed	`NCT00495690` - Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease	Phase 3